Shares of automation software company UiPath (NYSE: PATH) rallied 18.3% in December, according to data from S&P Global Market ...

UiPath (PATH) has been in focus after CEO Daniel Dines disclosed share sales under a pre arranged trading plan at the same time the company entered the S&P MidCap 400, which drew extra attention to ...

However, Palantir's huge gains have left the stock at a huge valuation; it's trading at a forward price-to-sales (P/S) ...

Model Context Protocol-based agentic integration allows for faster, more accurate access and usage of data and information to reduce errors and elevate productivity ...

If you are wondering whether UiPath's share price reflects its true worth or leaves some room on the table, you are in the right place. UiPath's stock closed at US$15.88, with a 5.7% decline over the ...

UiPath PATH saw its IBD SmartSelect Composite Rating rise to 96 Wednesday, up from 94 the day before. Please watch the video at Investors.com - Stock Market Exposure: How To Make Incremental Portfolio ...

RBC Capital lowered the firm’s price target on UiPath (PATH) to $17 from $19 and keeps a Sector Perform rating on the shares. 2026 is likely to be ...

UiPath Inc (NYSE:PATH) shares are moving higher in extended trading on Tuesday after it was announced the company will join the S&P Midcap 400.

UiPath, Inc. , a global leader in agentic automation, today announced that Ashim Gupta, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the 28th Annual ...

An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish. As you can see from the chart above the ...

Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

Figma went public at $33 last July and currently trades at approximately $37. UiPath went public at $56 in April 2021, but it ...